Although the majority of breast tumors are sporadic and do not carry germline mutations in BRCA1 or BRCA2 [14], it has been shown that the HR DNA repair pathway is frequently disrupted by numerous mechanisms [13, 15]. The gene discussed is BRCA2; the disease is breast neoplasm.